World Journal of Endocrine Surgery

Register      Login

VOLUME 9 , ISSUE 1 ( January-April, 2017 ) > List of Articles


The CaPTHUS Scoring Model revisited: Applicability from a UK Cohort with Primary Hyperparathyroidism

David M Scott-Coombes, Tobias W James, Michael J Stechman

Citation Information : Scott-Coombes DM, James TW, Stechman MJ. The CaPTHUS Scoring Model revisited: Applicability from a UK Cohort with Primary Hyperparathyroidism. World J Endoc Surg 2017; 9 (1):7-12.

DOI: 10.5005/jp-journals-10002-1199

Published Online: 01-04-2017

Copyright Statement:  Copyright © 2017; The Author(s).



Focused parathyroidectomy for primary hyperparathyroidism (pHPT) in patients with a single positive localizing scan may have an unacceptably high recurrence rate unless intraoperative parathyroid hormone (ioPTH) is used. The CaPTHUS score was previously developed to predict singlegland disease in such instances. We evaluated the accuracy of this model in a cohort of patients with pHPT in the UK.

Materials and methods

CaPTHUS scores were calculated from prospectively collected data on consecutive patients undergoing surgery for pHPT [(1 point each for: Preoperative calcium ≥3 mmol/L; PTH ≥2 times upper limit; ultrasound (1 point) and sestamibi (1 point) positive for single enlarged gland; concordant positive scans]. Diagnosis of single or multigland disease was confirmed on pathology.


From June 2007 to October 2011, 324 patients (251 female, median age 66, 10.89) underwent surgery for pHPT guided with ioPTH. Single-gland pathology was observed in 291 (89.8%) patients and multi-gland disease seen in 33 (10.2%). In single-gland disease patients, significantly higher preoperative calcium (p = 0.030) and PTH levels (p = 0.033) were seen with sensitivities of 65.6% for ultrasound and 66.0% for sestamibi scanning. A CaPTHUS score ≥3 was seen in 51.2% of all patients with a positive predictive value (PPV) for single-gland disease of 99.4%.


A CaPTHUS score ≥3 was accurate at predicting single-gland disease in >50% of patients with pHPT, providing a similar PPV and reducing the need for ioPTH implementation in this population. However, recent conflicting literature suggests the CaPTHUS score may not be universally applicable, local audit is recommended before implementation.

How to cite this article

James TW, Stechman MJ, Scott- Coombes DM. The CaPTHUS Scoring Model revisited: Applicability from a UK Cohort with Primary Hyperparathyroidism. World J Endoc Surg 2017;9(1):7-12.

PDF Share
  1. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002 Nov;17 (Suppl 2):N18-23.
  2. Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am 1998 Oct;7(4):721-748.
  3. Surg Clin North Am 2004 Jun;84(3):803-816.
  4. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011 Mar;253(3);585-591.
  5. Minimally invasive parathyroidectomy for primary hyperparathyroidism— current views, issues and controversies, hyperparathyroidism. In: Soto GD, Puig-Domingo M, editors- Chapter 3. 2012. p. 21-34.
  6. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. J Intern Med 1998 Feb;243(2):115-122.
  7. Minimally invasive parathyroidectomy in patients with previous endocrine surgery. JSLS 2011 Oct-Dec;15(4):499-503.
  8. 1000 minimally invasive parathyroidectomies without intra-operative parathyroid hormone measurement: lessons learned. ANZ J Surg 2011 May;81(5):362-365.
  9. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg 2004 Nov;28(11):1132-1138.
  10. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 2006 Aug;141(8):777-782.
  11. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg 2003 May;237(5):722-731.
  12. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 2006 Oct;140(4);665-674.
  13. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am 2004 Jun;84(3):717-734.
  14. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it “value-add” to decision-making? J Am Coll Surg 2006 Jul;203(1):1-6.
  15. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol (Oxf) 2007 Jun;66(6):878-885.
  16. Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 2007 Oct;205 (Suppl 4):S38-44.
  17. Cinical review: Parathyroid Localization and Implications for Clinical Management. J Clin Endocrinol Metab 2013 Mar;98(3):902-912.
  18. [Internet] [cited 2014 March]. Available from:
  19. CaPTHUS scoring model in primary hyperparthyroidism: can it eliminate the need for ioPTH Testing? Ann Surg Oncol 2015 Apr;22(4):1191-1195.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.